All Article Listing | RxWiki

Health News

Merck HIV Drug Demonstrates Efficacy

Merck announced final results from the STARTMRK study – the longest double-blind Phase III non-inferiority study evaluating an integrase inhibitor in treatment-naïve adults with HIV-1.

REFINE

medications
- - Remove Isentress filter (-) Remove Isentress filter Isentress
conditions
- - Remove Infectious Disease filter (-) Remove Infectious Disease filter Infectious Disease
    Remove Sexually Transmitted Disease filter Sexually Transmitted Disease
    Remove HIV AIDS filter (-) Remove HIV AIDS filter HIV AIDS